AIM Vaccine Co., Ltd. (AIM Vaccine or the Company, together with its subsidiaries, the Group, HKG: 6660), the second largest…
Browsing: BioTech
To Commence Trading on the Main Board of the Hong Kong Stock Exchange on 6 October 2022 AIM Vaccine Co.,…
PT Bio Farma (Persero), the holding company for pharmaceutical state-owned enterprises (SOEs), will export its novel Oral Polio Vaccine type…
Mainboard-listed Q&M Dental Group (Singapore) Limited [SGX: QC7] announced on 29 September 2022 the award of 2,014,245 shares to 7…
Transcenta Holding Limited (HKG:6628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based…
Avance Clinical, the leading Australian-based biotech CRO with US operations has won the South Australian Premier’s Export Awards – International…
Olympus Corporation (Olympus), a global medtech company committed to making people’s lives healthier, safer, and more fulfilling, today announced the…
Offer Price at HK$16.16 per Offer Share AIM Vaccine Co., Ltd. (AIM Vaccine or the Company, together with its subsidiaries,…
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce today a…
Successful In Vivo Testing Clears the Way for First Human Trial in Near Future HONG KONG, Sept 22, 2022 – (ACN Newswire) – Agilis…
Parties agree to collaborate on research in genetics, regenerative and alternative medicine Leading genomics and biopharmaceutical specialist Malaysian Genomics Resource…
Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Cell & Gene Therapy Clinical Trials award at…
Global markets in sight for shariah-compliant IndoVac vaccine brand PT Bio Farma, the holding company for state-owned pharmaceutical companies in…
Avance Clinical, the Australian CRO for biotechs, has expanded into North America with the acquisition of CRO partner company C3…
Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations,…
Meet the team at Booth #409 Novotech, the leading Asia Pacific biotech specialist CRO, will attend ESMO Congress 2022 with…
Legend Capital recently announced that it made its 100th IPO following the listing of its AI medical portfolio company Lunit…
Novotech, the leading Asia Pacific biotech specialist CRO has released new market data in a report now available titled “Evolution…
This year, CT Event Asia is all set to bring you the Asean Healthcare Transformation Summit 2022, themed “Leveraging Human…
As pharmaceutical reformation is underway, the importance of the innovative strength of biotech companies has become increasingly prominent, the entire…